Source: HID Blog

HID Blog Oncology Agents of 2016: A Clinical Review

Oncology management has evolved due to approval of new oncologic agents and their expensive costs. Previously, limited medication availability left practitioners with minimal options for cancer treatment. Newer cancer agents are designed to improve a patient's quality of life and hopefully, overall outcome. With the rapid development of new oncologic medications, the management process has posed a challenge to physicians and payers. Providing oncologic medications in the most cost-effective manner requires cost-management strategies to weigh the benefits and risks.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Robert Dibenedetto's photo - CEO of Health Information Designs, LLC

CEO

Robert Dibenedetto

CEO Approval Rating

67/100

Read more